Searchable abstracts of presentations at key conferences in endocrinology

ea0027oc3.2 | Oral Communications 3 | BSPED2011

Clinical, genetic, histological and radiological heterogeneity of focal forms of congenital hyperinsulinism

Ismail Dunia , Kapoor Ritika , Smith Virpi , Ashworth Michael , Blankenstein Oliver , Pierro Agostino , Flanagan Sarah , Ellard Sian , Hussain Khalid

Congenital hyperinsulinism (CHI) is a cause of severe and persistent hypoglycaemia due to unregulated insulin secretion from pancreatic β-cells. Mutations in the ABCC8 and KCNJ11 genes are the most common cause of medically unresponsive CHI. Histologically there are three major subgroups, focal, diffuse and atypical. The pathophysiology of focal CHI is complex and involves a two hit process with the patient firstly inheriting a paternal ABCC8/KCNJ11 m...

ea0027oc3.3 | Oral Communications 3 | BSPED2011

Laparoscopic near total pancreatectomy for medically unresponsive diffuse congenital hyperinsulinism

Pierro Agostino , Ron Ori , Nah Shireen , Smith Virpi , Ashworth Michael , Eaton Simon , Coppi Paulo Dr , Hussain Khalid

Background: Congenital hyperinsulinism (CHI) is cause of severe hyperinsulinaemic hypoglycaemia in the neonatal and infancy periods. Histologically there are three major subgroups, diffuse, focal and atypical. Patients with diffuse CHI who are medically unresponsive will require a near total pancreatectomy. This has traditionally been performed using an open surgical approach.Aims: To report our experience of laparoscopic near total pancreatectomy for me...

ea0033oc3.3 | Oral Communications 3 | BSPED2013

Successful treatment of four patients with severe hyperinsulinaemic hypoglycaemia with a novel therapy using mTOR inhibitor

Senniappan Senthil , Alexandrescu Sanda , Tatevian Nina , Shah Pratik , Arya Ved , Flanagan Sarah , Ellard Sian , Rampling Dyanne , Ashworth Michael , Brown Robert , Hussain Khalid

Introduction: Hyperinsulinaemic hypoglycaemia (HH) is the most common cause of severe and persistent hypoglycaemia in neonates. The treatment of diazoxide unresponsive HH involves pancreatectomy. Mammalian target of rapamycin (mTOR) is a protein kinase that regulates cellular proliferation. We aimed to evaluate the efficacy of mTOR inhibitor Sirolimus and assess mTOR expression in the pancreas of infants with severe HH.Methods: Four infants with severe, ...